(Q71015617)

English

Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group

scientific article published on 01 January 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607394%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607394%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

atrial fibrillation

1 reference

based on heuristic

inferred from title

author name string

E Aliot

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607394%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

I Denjoy

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607394%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

language of work or name

0 references

publication date

1 January 1996

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607394%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607394%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

77

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607394%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607394%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

66A-71A

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607394%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989120-5

7 January 2021

Flecainide acetate in the prevention of paroxysmal atrial fibrillation: a nine-month follow-up of more than 500 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989120-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989120-5

7 January 2021

A randomized double-blind crossover study comparing the efficacy and tolerability of flecainide and quinidine in the control of patients with symptomatic paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989120-5

7 January 2021

Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989120-5

7 January 2021

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989120-5

7 January 2021

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989120-5

7 January 2021

Propafenone for prevention of recurrent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989120-5

7 January 2021

Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989120-5

7 January 2021

Comparison of mortality in patients treated with propafenone to those treated with a variety of antiarrhythmic drugs for supraventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989120-5

7 January 2021

Propafenone for paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989120-5

7 January 2021

Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989120-5

7 January 2021

Identifiers

10.1016/S0002-9149(97)89120-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607394%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607394%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71015617&oldid=1942412919"